Can G-CSF cause leukemia in hematopoietic stem cell donors?

Belinda R. Avalos, Aleksandr Lazaryan, Edward A. Copelan

Research output: Contribution to journalReview articlepeer-review

29 Scopus citations


A large majority of allogeneic hematopoietic stem cell donations are achieved using granulocyte-colony stimulating factor (G-CSF). G-CSF use has been associated with later development of myelodysplastic syndromes/acute myelogenous leukemia (MDS/AML) in several clinical circumstances. Although clinical data to date have failed to identify any increased incidence of MDS/AML in G-CSF mobilized donors, the quality of these data are insufficient to exclude a long-term risk. Physicians should explain the potential risk to donors, and where appropriate, offer donors the option of marrow donation.

Original languageEnglish (US)
Pages (from-to)1739-1746
Number of pages8
JournalBiology of Blood and Marrow Transplantation
Issue number12
StatePublished - Dec 2011


  • G-CSF
  • Peripheral blood progenitor cell mobilization
  • Stem cell donors


Dive into the research topics of 'Can G-CSF cause leukemia in hematopoietic stem cell donors?'. Together they form a unique fingerprint.

Cite this